Location: London, United Kingdom
CIK: 0001536114 · Show all filings
Period: Q3 2019 (← Previous) (Next →)
Filing Date: Nov 5, 2019
Total Value: $144M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| VGSH | VANGUARD SCOTTSDALE FDS | 1,087,088 | $66.26M | 45.9% | $60.95 | $60.05 | +1.5% | SHTRM GVT BD ETF | 92206C102 |
| VOO | VANGUARD INDEX FDS | 131,165 | $35.76M | 24.8% | $272.60 | $232.60 | +17.2% | S&P 500 ETF SHS | 922908363 |
| VEU | MFC VANGUARD INTL EQUITY INDEX FDS | 588,511 | $29.37M | 20.4% | $49.90 | $47.05 | +6.0% | ALLWRLD EX US | 922042775 |
| — | REATA PHARMACEUTICALS INC | 160,628 | $12.9M | 8.9% | $80.29 | $80.29 | — | CLASS A | 75615P103 |